Deepti Behl, M.D., is a medical oncologist and medical director of the lung cancer program at Sutter Medical Center, Sacramento. She is also the medical director for the Sutter Institute for Medical Research (SIMR) in Sacramento, and Chair, Sutter-wide Melanoma Program of Distinction (POD). She completed her residency and fellowship training in hematology and oncology at the Mayo Clinic, Rochester, MN. Her medical school was Christian Medical College, Ludhiana, India.
She is Board certified in medical oncology and hospice and palliative care, and focuses on lung cancer and melanoma. She is also currently enrolled in the University of Arizona, Andrew Weil Fellowship in Integrative Medicine, and expected to graduate in the fall of 2023.
She is a member of the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), Society for immunotherapy for Cancer (SITC), International Association for the Study of Lung Cancer (IASLC) and Society of Integrative Oncology (SIO).